Literature DB >> 14609517

The effects of cycle racing on pulmonary diffusion capacity and left ventricular systolic function.

Michael K Stickland1, Stewart R Petersen, Mark J Haykowsky, Dylan A Taylor, Richard L Jones.   

Abstract

The purpose of this study was to examine the effects of a 20 km cycle race (TT) on left ventricular (LV) systolic and pulmonary function in 12 endurance cyclists. Spirometry, single-breath diffusion capacity (DLCO) with partitioning of membrane (DM) and capillary blood volume (Vc) components and 2-D echocardiograms were performed before and after the TT. During the TT mean oxygen consumption was 3.79 +/- 0.5 L x min(-1) (83 +/- 5.5% of VO2max) and mean blood lactate was 8.4 +/- 2.4 mM. Following the TT, spirometry values were unchanged, however, DLCO and DM were significantly (P<0.05) reduced. LV systolic function was increased (P<0.05) immediately after exercise, while end-diastolic area was decreased (P<0.05) at all points during recovery. The reduction in DM was correlated with LV systolic function following the TT. This relationship suggests a cardiovascular contribution to pulmonary diffusion impairment following exercise.

Entities:  

Mesh:

Year:  2003        PMID: 14609517     DOI: 10.1016/s1569-9048(03)00198-8

Source DB:  PubMed          Journal:  Respir Physiol Neurobiol        ISSN: 1569-9048            Impact factor:   1.931


  2 in total

Review 1.  Pulmonary gas exchange and acid-base balance during exercise.

Authors:  Michael K Stickland; Michael I Lindinger; I Mark Olfert; George J F Heigenhauser; Susan R Hopkins
Journal:  Compr Physiol       Date:  2013-04       Impact factor: 9.090

2.  Reduction in Post-Marathon Peak Oxygen Consumption: Sign of Cardiac Fatigue in Amateur Runners?

Authors:  Ana Paula Rennó Sierra; Anderson Donelli da Silveira; Ricardo Contesini Francisco; Rodrigo Bellios de Mattos Barretto; Carlos Anibal Sierra; Romeu Sergio Meneghelo; Maria Augusta Peduti Dal Molin Kiss; Nabil Ghorayeb; Ricardo Stein
Journal:  Arq Bras Cardiol       Date:  2016-01-12       Impact factor: 2.000

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.